Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Molecular Geodesics, Inc. was a pioneering biotechnology and materials science company founded in 1996 by Dr. Donald Ingber of Harvard Medical School. The company focused on the development of biomimetic materials and tissue engineering scaffolds based on the principles of "tensegrity"—a structural system of balanced tension and compression found in living cells and tissues. Utilizing proprietary "combinatorial geodesics" software and advanced 3D printing technologies like stereolithography, the company aimed to create high-strength, lightweight materials for medical implants, biodefense, and industrial applications. Although the company later changed its name to Tensegra, Inc. and eventually ceased operations, its work laid the foundation for modern biologically inspired engineering and the commercialization of organ-on-a-chip technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Molecular Geodesics.